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ABSTRACT
CONTEXT: Gastric stump cancer after gastric resection is a well-known disease. It may be a newly de-
veloped cancer after resection due to benign disease, or recurrent or residual disease after oncological 
surgery. The predominant histological type is usually adenocarcinoma. This study aimed to report on a rare 
occurrence of a mixed adenoneuroendocrine carcinoma (MANEC) on the gastric stump. 
CASE REPORT: The case of an 83-year-old female who presented a locally aggressive gastric stump 
MANEC, 35 years after Billroth II gastrectomy to treat a peptic ulcer, is reported. The patient underwent 
resection and adjuvant therapy. She has been followed up for one year without signs of recurrence. 
CONCLUSION: MANEC is a rare type of gastrointestinal neoplasm. The classification, histopathology, clini-
cal features, treatment issues and prognosis are discussed along with a brief review of the literature. 
RESUMO
CONTEXTO: O câncer de coto gástrico após gastrectomia é uma condição extensamente documentada. 
Pode se tratar de doença desenvolvida após a ressecção por doença benigna, ou ainda doença recorrente 
ou residual após cirurgia oncológica. Geralmente, o tipo histológico predominante é o adenocarcinoma. 
Este estudo tem como propósito relatar a rara ocorrência de um adenocarcinoma neuroendócrino misto 
(MANEC) no coto gástrico.
RELATO DE CASO: É relatado o caso de uma mulher de 83 anos que apresentou um MANEC localmente 
agressivo 35 anos após uma gastrectomia à Billroth II devido a úlcera péptica. Foi submetida a ressecção e 
terapia adjuvante e foi seguida por 12 meses sem sinais de recorrência.
CONCLUSÃO: Os MANECs constituem raro tipo de neoplasia gastrointestinal. Sua classificação, histopato-
logia, aspectos clínicos, tratamento e prognóstico são discutidos junto com uma breve revisão de literatura.
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INTRODUCTION
Occurrences of gastric stump cancer (GSC) after partial gastric 
resection, especially when Billroth II reconstruction is carried 
out, are a well-recognized problem.1,2 GSC was classified into 
three categories by Kidokoro et al.:3 cancer newly developed in 
the remnant stomach; recurrent cancer in the remnant stomach; 
and cancer remaining in the remnant stomach after the initial 
gastric surgery. The carcinogenesis of newly developed GSC is 
strongly associated with chronic duodenogastric reflux of bile 
and pancreatic juice, and hypochlorhydria secondary to dener-
vation through vagotomy.1,3,4 
Because a great number of younger patients underwent this 
procedure over the decades prior to the introduction of more 
effective drug therapies against peptic disease that have been 
developed lately, a significant number of individuals are exposed 
to higher risk of gastric cancer nowadays. It is generally reported 
that chronic degenerative changes to the gastric mucosa lead to 
development of adenocarcinoma with varying degrees of differ-
entiation.4 There are no previously reported cases of mixed ade-
noneuroendocrine carcinoma (MANEC) arising in the gastric 
stump subsequent to Billroth II gastrectomy.
CASE REPORT
An 83-year-old female sought assistance due to weight loss 
(10 kg), epigastric fullness and regurgitation of solid food over 
a three-month period. The patient presented mild hyperten-
sion that was under control by means of monotherapy (enala-
pril maleate) and had undergone partial gastric resection due to 
a peptic ulcer 35 years earlier. 
On clinical examination, an epigastric mass was palpated. 
Rectal and vaginal examinations showed no alterations. From 
esophagogastroscopy, the following were observed: Billroth II 
gastrectomy and diffuse thickening and infiltrative appearance 
of the gastric stump mucosa, from the esophagogastric junc-
tion to the gastrojejunostomy site, suggestive of linitis plastica. 
Histopathological examination revealed poorly differentiated 
adenocarcinoma with signet ring cells. A computed tomog-
raphy scan showed a thickening of the gastric stump from the 
cardia to the gastrojejunostomy site; there was apparent inva-
sion of the transverse colon and pancreas tail. Colonoscopy con-
firmed  the presence of transmural invasion of the colon. 
The patient underwent open total gastrectomy along with D2 
lymphadenectomy, segmental colectomy, distal pancreatectomy, 
splenectomy, cholecystectomy and Roux-en-Y reconstruction. 
The operation lasted four hours and the patient was then moved 
to the intensive care unit. During the postoperative period, the 
patient presented nosocomial pneumonia that required treated 
using broad-spectrum antibiotic therapy and developed deep 
venous thrombosis in her left leg that needed anticoagulation. 
Enteral nutrition through a jejunostomy was introduced on 
the  fourth day after the operation and oral feeding was started 
on  the tenth day. The patient was discharged from hospital 
28 days after surgery, at the time when antibiotic therapy ended 
and anticoagulation with oral drugs had been achieved.
Histopathological examination on the surgical specimen 
revealed that it comprised a poorly differentiated, ulcerated ade-
nocarcinoma with signet ring cells, which infiltrated the gastric 
wall and invaded the colon segment. Angiolymphatic and peri-
neural invasion were present; the surgical margins were free; none 
of the lymph node presented metastases (0/15); the TNM classi-
fication was T4N0 (stage IIIA). Immunohistochemical analysis 
revealed diffuse positivity for AE1/AE3; 40% of the sample was 
positive for chromogranin A and synaptophysin, thus character-
izing a differentiated neuroendocrine tumor (NET). Hence, the 
diagnosis of gastric stump intermediate-grade malignant mixed 
adenoneuroendocrine carcinoma (MANEC) was confirmed, 
with predominance of the exocrine phenotype. 
Adjuvant therapy was used based on the most common 
tumor cell type, and the most aggressive type (adenocarcinoma) 
was taken into consideration. We used postoperative bolus-based 
chemotherapy consisting of a combination of 5-fluorouracil 
(5-FU) plus leucovorin (LEU), along with sandwiched chemora-
diation therapy of a bolus of 5-FU plus LEU as a radiosensitizer.5 
The patient presented mild symptoms during the first two 
courses of chemotherapy, such as abdominal pain, nausea and 
vomiting, but no dose reduction was applied. The third course 
was administered with concomitant locoregional radiotherapy. 
After ten days, the patient presented significant gastrointestinal 
symptoms comprising diarrhea, nausea, vomiting and abdomi-
nal pain, and the radiation therapy was suspended. The treatment 
continued with chemotherapy alone until five cycles had been 
completed, with mild gastrointestinal symptoms. The patient has 
been followed up for one year since the surgery, and the last CT 
scan did not show any signs of recurrence.
DISCUSSION
MANECs of the gastrointestinal tract are rare tumors.6 A wide 
spectrum of possible combinations of exocrine and neuroendo-
crine components has been recognized, ranging from adenomas 
or carcinomas with interspersed neuroendocrine cells to typical 
NET with a focal exocrine component.6,7 Both the exocrine and 
the neuroendocrine components may present different morpho-
logical characteristics. For the former, these range from adeno-
mas to adenocarcinomas with varying degrees of differentiation, 
while for the latter, these range from well to poorly differentiated 
NET.7 A tumor is considered to be of mixed exocrine and neuro-
endocrine type when at least 30% of the lesion is represented by 
one of the components.8
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A review of the literature was conducted through an online 
search for the MeSH terms gastric stump and stomach neoplasms 
in Medline (via PubMed); and for the MeSH/DeCS terms gastric 
stump and stomach neoplasms in Lilacs (via Bireme) (Table 1). 
There were no cases in which the histopathological findings were 
similar to those reported in this study.
Mixed exocrine-neuroendocrine neoplasms can be grouped 
into different prognostic categories according to the grade of 
malignancy of each component.6,7 They are classified as follows: 
1) high-grade malignant MANEC: combination of an adeno-
matous or carcinomatous component with a poorly differen-
tiated (small, intermediate or large cell type) neuroendocrine 
carcinoma (NEC); 2) intermediate-grade malignant MANEC: 
this group includes mixed adenocarcinoma-neuroendocrine 
tumors (adenocarcinoma/carcinoma that may show different 
degrees of differentiation, combined with a differentiated NET) 
and amphicrine carcinoma (a peculiar form of tumor in which 
the same neoplastic cells coexpress both endocrine and exocrine 
features, with varying grades of differentiation); 3) low-grade 
malignant mixed adenoneuroendocrine tumor: neoplasms com-
posed of well-differentiated neuroendocrine and exocrine cells 
that generally have indolent behavior.6
Mixed adenocarcinoma-neuroendocrine tumors, which are 
in the intermediate-grade category, are formed by areas of tubu-
lar, papillary or mucinous adenocarcinoma and areas of grade 1 or 
2 NET.6,7 Unlike high grade MANECs, the exocrine component is 
usually more aggressive than the neuroendocrine component. 
There  are approximately 60 reported cases in the literature, 
throughout the gastrointestinal tract. They are more prevalent in 
men in their fifth to sixth decades of life. In the stomach, their 
distribution is equal in the antrum and in the body.6 This group 
also includes poorly cohesive neuroendocrine carcinoma, in 
which there are noncohesive signet ring cells mixed with neuro-
endocrine cells. This subtype often involves the whole stomach 
with a pattern of linitis plastica.6,9,10 
There is no optimal management strategy to date, because 
of the rarity of this pathological condition.6 The most aggres-
sive component should be taken into account when treatment 
options are considered.11-13 Tumors with a poorly differentiated 
neuroendocrine carcinoma component must be treated as neu-
roendocrine carcinomas; tumors composed of an adenocarci-
noma along with well-differentiated NET must be treated  as 
adenocarcinoma.6,11 Surgical resection is mostly indicated and 
must be followed by adjuvant therapy. Early diagnosis is an 
important factor for avoiding extensive resection like in the 
case reported in this study.14
The prognosis for patients with MANECs is not well-defined.15,16 
The data available suggest that high grade MANECs appear to lead 
to better overall survival than do pure neuroendocrine carcinomas. 
Intermediate-grade MANECs do not yet have any defined overall 
prognosis.6,17,18 Specifically, when the mixed poorly cohesive neuro-
endocrine carcinoma is presented in linitis plastica form, this leads 
to a poor prognosis, such that most patients die within 10 months 
of the surgery.18 The case reported in the present paper, which was 
of this subtype, had an unusual outcome, probably due to nonoc-
currence of lymph node involvement or distant metastasis, despite 
the locally aggressive pattern observed. In classical cases of newly 
developed adenocarcinoma of the gastric stump, the overall sur-
vival rate is very similar to what is observed in cases of primary 
gastric cancer. Conversely, for patients whose prior resection was 
due to malignant disease, the prognosis is even more somber.1,19
The specific carcinogenetic pathways that lead to mixed exo-
crine-neuroendocrine lesions are largely unknown.14-16 Whether 
these can be correlated with the classical mechanisms described 
for gastric stump cancer development remains to be better under-
stood. The case reported here was a rare malignant neoplasm that 
developed with a somewhat unusual presentation. Because of the 
scarcity of data on these specific issues, further study is needed in 
order to determine issues regarding pathophysiology, treatment 
options and prognosis, with better accuracy.
CONCLUSION
Gastric MANECs are rare tumors and this study presents the 
even more unusual occurrence of MANEC in the gastric stump 
following Billroth II gastrectomy. Because of the scarcity of such 
cases, further research is needed in order to determine novel 
diagnostic and therapeutic approaches.
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